1. Home
  2. IVVD vs NKLR Comparison

IVVD vs NKLR Comparison

Compare IVVD & NKLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • NKLR
  • Stock Information
  • Founded
  • IVVD 2020
  • NKLR 2018
  • Country
  • IVVD United States
  • NKLR Italy
  • Employees
  • IVVD N/A
  • NKLR N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • NKLR Metal Fabrications
  • Sector
  • IVVD Health Care
  • NKLR Industrials
  • Exchange
  • IVVD Nasdaq
  • NKLR Nasdaq
  • Market Cap
  • IVVD 412.6M
  • NKLR 398.3M
  • IPO Year
  • IVVD 2021
  • NKLR N/A
  • Fundamental
  • Price
  • IVVD $2.57
  • NKLR $4.47
  • Analyst Decision
  • IVVD Strong Buy
  • NKLR
  • Analyst Count
  • IVVD 5
  • NKLR 0
  • Target Price
  • IVVD $6.11
  • NKLR N/A
  • AVG Volume (30 Days)
  • IVVD 11.9M
  • NKLR 1.3M
  • Earning Date
  • IVVD 11-06-2025
  • NKLR 01-01-0001
  • Dividend Yield
  • IVVD N/A
  • NKLR N/A
  • EPS Growth
  • IVVD N/A
  • NKLR N/A
  • EPS
  • IVVD N/A
  • NKLR N/A
  • Revenue
  • IVVD $50,039,000.00
  • NKLR N/A
  • Revenue This Year
  • IVVD $102.11
  • NKLR N/A
  • Revenue Next Year
  • IVVD $151.51
  • NKLR N/A
  • P/E Ratio
  • IVVD N/A
  • NKLR N/A
  • Revenue Growth
  • IVVD 332.71
  • NKLR N/A
  • 52 Week Low
  • IVVD $0.35
  • NKLR $3.73
  • 52 Week High
  • IVVD $3.07
  • NKLR $21.91
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 64.50
  • NKLR N/A
  • Support Level
  • IVVD $2.38
  • NKLR N/A
  • Resistance Level
  • IVVD $2.70
  • NKLR N/A
  • Average True Range (ATR)
  • IVVD 0.25
  • NKLR 0.00
  • MACD
  • IVVD 0.07
  • NKLR 0.00
  • Stochastic Oscillator
  • IVVD 69.01
  • NKLR 0.00

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About NKLR Terra Innovatum Global N.V. Ordinary shares

Terra Innovatum Global NV is a micro modular nuclear solutions company that aims to deliver reliable, low-cost and zero-carbon power wherever energy demand is present through its first-of-a-kind reactor SOLO. SOLO is compact yet extremely powerful with one unit generating 1MWe of power, while designed with the strictest safety characteristics and the ability to run 24/7 without the need to refuel for 15 years. Its modular design aims to achieve maximum energy efficiency while significantly reducing the levelized cost of energy (LCOE). SOLO is built using off-the-shelf components and widely available fuel, low-enriched uranium (LEU), which de-risks its regulatory and commercial pathway.

Share on Social Networks: